NM_000181.4:c.1790-4G>T
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_StrongBP6_Moderate
The NM_000181.4(GUSB):c.1790-4G>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0020 ( 0 hom., cov: 29)
Exomes 𝑓: 0.0075 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
GUSB
NM_000181.4 splice_region, intron
NM_000181.4 splice_region, intron
Scores
2
Splicing: ADA: 0.00002440
2
Clinical Significance
Conservation
PhyloP100: -0.296
Publications
0 publications found
Genes affected
GUSB (HGNC:4696): (glucuronidase beta) This gene encodes a hydrolase that degrades glycosaminoglycans, including heparan sulfate, dermatan sulfate, and chondroitin-4,6-sulfate. The enzyme forms a homotetramer that is localized to the lysosome. Mutations in this gene result in mucopolysaccharidosis type VII. Alternative splicing results in multiple transcript variants. There are many pseudogenes of this locus in the human genome.[provided by RefSeq, May 2014]
GUSB Gene-Disease associations (from GenCC):
- mucopolysaccharidosis type 7Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -6 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 7-65961067-C-A is Benign according to our data. Variant chr7-65961067-C-A is described in ClinVar as Likely_benign. ClinVar VariationId is 458509.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00204 AC: 217AN: 106558Hom.: 0 Cov.: 29 show subpopulations
GnomAD3 genomes
AF:
AC:
217
AN:
106558
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0301 AC: 4803AN: 159490 AF XY: 0.0295 show subpopulations
GnomAD2 exomes
AF:
AC:
4803
AN:
159490
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00748 AC: 10087AN: 1348104Hom.: 0 Cov.: 35 AF XY: 0.00794 AC XY: 5355AN XY: 674436 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
10087
AN:
1348104
Hom.:
Cov.:
35
AF XY:
AC XY:
5355
AN XY:
674436
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
573
AN:
31272
American (AMR)
AF:
AC:
1953
AN:
43328
Ashkenazi Jewish (ASJ)
AF:
AC:
322
AN:
25174
East Asian (EAS)
AF:
AC:
237
AN:
38560
South Asian (SAS)
AF:
AC:
1622
AN:
83366
European-Finnish (FIN)
AF:
AC:
1875
AN:
46738
Middle Eastern (MID)
AF:
AC:
77
AN:
4964
European-Non Finnish (NFE)
AF:
AC:
3059
AN:
1018242
Other (OTH)
AF:
AC:
369
AN:
56460
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
488
976
1464
1952
2440
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.00205 AC: 218AN: 106592Hom.: 0 Cov.: 29 AF XY: 0.00222 AC XY: 113AN XY: 50814 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
218
AN:
106592
Hom.:
Cov.:
29
AF XY:
AC XY:
113
AN XY:
50814
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
34
AN:
28244
American (AMR)
AF:
AC:
6
AN:
10150
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
2654
East Asian (EAS)
AF:
AC:
1
AN:
3788
South Asian (SAS)
AF:
AC:
6
AN:
3492
European-Finnish (FIN)
AF:
AC:
71
AN:
5970
Middle Eastern (MID)
AF:
AC:
0
AN:
202
European-Non Finnish (NFE)
AF:
AC:
96
AN:
50048
Other (OTH)
AF:
AC:
3
AN:
1472
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.295
Heterozygous variant carriers
0
20
40
60
80
100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Mucopolysaccharidosis type 7 Benign:1
Feb 09, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.